He has expertise in the treatment of urological cancers and research on prostate cancer in men of African descent. He contributed to running an NIH funded research project on prostate cancer under Dr Serigne Gueye co-PI in collaboration with Dr Timothy Rebbeck co-PI from University of Harvard. Such research focused on a better understanding of clinical and molecular epidemiology of prostate cancer in Senegalese men with an emphasis on developing research infrastructure.
This research was further enlarged to form the consortium Men of African Descent Carcinoma of the Prostate (MADCaP). Through MADCaP, Dr Jalloh is Co-Investigator in NIH/NCI funded grants to study the Genetic Epidemiology of Prostate Cancer in Africa and to train next generation of cancer researchers.
In 2013, he completed a post-doctoral scholarship training in Urologic Oncology at the University of California San Francisco under Dr Peter R Carroll, MD and published many peer-reviewed papers on prostate cancer.
In 2015, he completed a Masters of Public Health: Management and Control of health programme at the University Alioune Diop of Bambey, Senegal and has become a PhD in 2024 at the University Iba der Thiam of Thies, Senegal with his research on Prostate cancer.
He has served as the Secretary General of the Senegalese Association of Urologist
(ASU) for the period 2022-2026.
In 2024, he served as the Chairman of the local organizing committee of the 14th
AORTIC Conference in Dakar.
He is currently the president elect of the Pan African Urological Surgeons’ Association
